参考文献/References:
[1]Molteni M,Polo Friz H,Primitz L,et al.The definition of valvular and non-valvular atrial fibrillation:results of a physicians'survey[J].Europace,2014,16(12):1720-1725.
[2]He X,Gao X,Peng L,et al.Atrial fibrillation induces myocardial fibrosis through angiotensin Ⅱ type 1 receptor-specific Arkadia-mediated downregulation of Smad7[J].Circ Res,2011,108(2):164-175.
[3]Platonov PG.Atrial fibrosis:an obligatory component of arrhythmia mechanisms in atrial fibrillation[J].J Geriatr Cardiol,2017,14(4):233-237.
[4]Weng X,Yu L,Liang P,et al.A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin Ⅱ-induced cardiac hypertrophy[J].J Mol Cell Cardiol,2015(82):48-58.
[5]Aránguiz-Urroz P,Soto D,Contreras A,et al.Differential participation of angiotensin Ⅱ type 1 and 2 receptors in the regulation of cardiac cell death triggered by angiotensin Ⅱ[J].Am J Hypertens,2009,22(5):569-576.
[6]Ichihara S,Senbonmatsu T,Price E Jr,et al.Targeted deletion of angiotensin Ⅱ type 2 receptor caused cardiac rupture after acute myocardial infarction[J].Circulation,2002,106(17):2244-2249.
[7]Tadevosyan A,Xiao J,Surinkaew S,et al.Intracellular Angiotensin-Ⅱ Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis,Cell Proliferation,and Collagen Secretion[J].J Am Heart Assoc,2017,6(4):e004965.
[8]Zhang Y,Zhao NA,Wang JK,et al.Telmisartan inhibited angiotensinⅡ-induced collagen metabolic imbalance without directly targeting TGF-β1/Smad signaling pathway in cardiac fibroblasts[J].Minerva Cardioangiol,2015,63(6):507-514.
[9]Haspula D,Clark MA.MAPKactivation patterns of AT1R and CB1R in SHR versus Wistar astrocytes:Evidence of CB1R hypofunction and crosstalk between AT1R and CB1R[J].Cell Signal,2017(40):81-90.
[10]Li X,Rao F,Deng CY,et al.Involvement of ERK1/2in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes[J].Clin Exp Pharmacol Physiol,2017,44(7):771-778.
[11]Hu J,Wang X,Wei SM,et al.Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 andp38-MAPK pathways[J].Eur J Pharmacol,2016(789):319-327.
[12]Zheng L,Jia X,Zhang C,et al.Angiotensin Ⅱ in atrial structural remodeling:the role of Ang Ⅱ/JAK/STAT3 signaling pathway[J].Am J Transl Res,2015,7(6):1021-1031.
[13]Nattel S,Harada M.Atrial remodeling and atrial fibrillation:recent advances and translational perspectives[J].J Am Coll Cardiol,2014,63(22):2335-2345.
[14]Ock S,Lee WS,Ahn J,et al.Deletionof IGF-1 Receptors in Cardiomyocytes Attenuates Cardiac Aging in Male Mice[J].Endocrinology,2016,157(1):336-345.
[15]Wang WW,Zhang FL,Chen JH,et al.Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS-ERK and PI3K-Akt-eNOSpathways in spontaneously hypertensive rats[J].Can J Physiol Pharmacol,2015,93(8):657-665.
[16]Wang ZG,Wang Y,Huang Y,et al.bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia reperfusion via the activation of the PI3K/Akt/mTOR pathway[J].Sci Rep,2015(5):9287.
[17]Spangle JM,Dreijerink KM,Groner AC,et al.PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer[J].Cell Rep,2016,15(12):2692-2704.
[18]Brier AB,Loft A,Madsen JGS,et al.The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation[J].Nucleic Acids Res,2017,45(4):1743-1759.
[19]Shahid M,Spagnolli E,Ernande L,et al.BMP type I receptor ALK2 is required for angiotensin Ⅱ-induced cardiac hypertrophy[J].Am J Physiol Heart Circ Physiol,2016,310(8):H984-H994.
[20]Gong F,Clouaire T,Aguirrebengoa M,et al.Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair[J].J Cell Biol,2017,216(7):1959-1974.
相似文献/References:
[1]张定欣,林先和.经食道三维超声在房颤二尖瓣结构变化对其
返流程度影响中的应用[J].医学信息,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
ZHANG Ding-xin,LIN Xian-he.Application of Transesophageal Three-dimensional Ultrasound in the Influence of Mitral Valve Structure Changes on the Degree of Reflux in Atrial Fibrillation[J].Journal of Medical Information,2018,31(12):76.[doi:10.3969/j.issn.1006-1959.2018.12.023]
[2]王淑娟,林祥灿.血浆NT-proBNP水平与同型半胱氨酸对
糖尿病合并心房颤动的相关性研究[J].医学信息,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
WANG Shu-juan,LIN Xiang-can.Correlation between Plasma NT-proBNP level and Homocysteine in Patients with Diabetes Mellitus Complicated with Atrial Fibrillation[J].Journal of Medical Information,2018,31(12):169.[doi:10.3969/j.issn.1006-1959.2018.14.053]
[3]陶春艳.柔性护理在胺碘酮治疗心房颤动护理中的应用研究[J].医学信息,2018,31(24):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
TAO Chun-yan.Application of Flexible Nursing in the Treatment of Atrial Fibrillation with Amiodarone[J].Journal of Medical Information,2018,31(12):154.[doi:10.3969/j.issn.1006-1959.2018.24.046]
[4]古俊楠,张牧秋,王建强,等.可穿戴设备在心房颤动诊治中的应用[J].医学信息,2019,32(15):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
GU Jun-nan,ZHANG Mu-qiu,WANG Jian-qiang,et al.Application of Wearable Devices in the Diagnosis and Treatment of Atrial Fibrillation[J].Journal of Medical Information,2019,32(12):34.[doi:10.3969/j.issn.1006-1959.2019.15.012]
[5]刘 瑜,王建强,古俊楠,等.房颤合并功能性二尖瓣返流研究[J].医学信息,2019,32(15):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
LIU Yu,WANG Jian-qiang,GU Jun-nan,et al.Study on Atrial Fibrillation Combined with Functional Mitral Regurgitation[J].Journal of Medical Information,2019,32(12):51.[doi:10.3969/j.issn.1006-1959.2019.15.017]
[6]张牧秋,古俊楠,刘 瑜,等.NOACS治疗房颤合并急性冠脉综合征的研究[J].医学信息,2019,32(13):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
ZHANG Mu-qiu,GU Jun-nan,LIU Yu,et al.Study of NOACS in the Treatment of Atrial Fibrillation Complicated with Acute Coronary Syndrome[J].Journal of Medical Information,2019,32(12):28.[doi:10.3969/j.issn.1006-1959.2019.13.010]
[7]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,32(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with
Atrial Fibrillation and ACS[J].Journal of Medical Information,2019,32(12):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
[8]朱文书,张理想,游杨杨,等.长链非编码RNA MIAT表达水平与心房颤动导管消融术后复发的关系[J].医学信息,2021,34(04):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
ZHU Wen-shu,ZHANG Li-xiang,YOU Yang-yang,et al.Relationship Between the Expression Level of Long Non-coding RNA MIAT and Recurrence After Catheter Ablation of Atrial Fibrillation[J].Journal of Medical Information,2021,34(12):75.[doi:10.3969/j.issn.1006-1959.2021.04.020]
[9]马 利,李丽华.aVR导联法在心房颤动伴宽QRS波群心动过速鉴别诊断中的应用[J].医学信息,2022,35(19):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
MA Li,LI Li-hua.Application of aVR Lead Method in Differential Diagnosis of Atrial Fibrillation with Wide QRS Complex Tachycardia[J].Journal of Medical Information,2022,35(12):142.[doi:10.3969/j.issn.1006-1959.2022.19.041]
[10]陈启松,何海军,谷光敏,等.IL-6基因多态性与心房颤动相关性的Meta分析[J].医学信息,2020,33(23):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]
CHEN Qi-song,HE Hai-jun,GU Guang-min,et al.Meta Analysis of the Correlation Between IL-6 Gene Polymorphism and Atrial Fibrillation[J].Journal of Medical Information,2020,33(12):73.[doi:10.3969/j.issn.1006-1959.2020.23.021]